It is not terrible
Retatrutides Phase 2 data at 12 mg showed lower GI side effect rates across the board: nausea at 28%, diarrhea at 23%, constipation at 17%, and vomiting at 12%
Krivic et al., 2008) ligament-healing (Sebecic et al., 1999) (and in other models, such as is observed with rat femoral head osteonecrosis (Gamulin et al., 2013), or alveolar bone loss (Keremi et al., 2009)
Research and clinical practice commonly use various thresholds, including regaining more than 25% of maximum weight lost or achieving a body mass index (BMI) above 35 kg/m with obesity-related comorbidities
No hidden fees, membership, or subscription required
COURAGE from Regeneron, EMBRAZE from Scholar Rock, and BELIEVE from Lilly (Versanis) read out this month